RPL22 and cancer: Also, these findings do not explain why RPL22/eL22 is highly mutated in several human solid tumors [2, 3], as analysis of human cancer databases available from cBioPortal revealed that RPL22/eL22 is actually highly mutated in multiple cancer types and in a pool of cancer cell lines, and more than 85% mutations are deletion mutations (Figure 1).